<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?origin publisher?><?FILEmeta_STEM435 xml ?><?FILEmain xml ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEgr7 jpg ?><?FILEmmc1 pdf ?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Stem Cell</journal-id><journal-title>Cell Stem Cell</journal-title><issn pub-type="ppub">1934-5909</issn><issn pub-type="epub">1875-9777</issn><publisher><publisher-name>Cell Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">STEM435</article-id><article-id pub-id-type="doi">10.1016/j.stem.2009.04.014</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian Epidermis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jensen</surname><given-names>Kim B.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Collins</surname><given-names>Charlotte A.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Nascimento</surname><given-names>Elisabete</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Tan</surname><given-names>David W.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Frye</surname><given-names>Michaela</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Itami</surname><given-names>Satoshi</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Watt</surname><given-names>Fiona M.</given-names></name><email>fiona.watt@cancer.org.uk</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff4" ref-type="aff">4</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><addr-line><sup>1</sup>Laboratory for Epidermal Stem Cell Biology, Wellcome Trust Centre for Stem Cell Research, University of Cambridge, Cambridge CB2 1QR, UK</addr-line></aff><aff id="aff2"><addr-line><sup>2</sup>Laboratory for Epithelial Stem Cell Homeostasis and Cancer, Wellcome Trust Centre for Stem Cell Research, University of Cambridge, Cambridge CB2 1QR, UK</addr-line></aff><aff id="aff3"><addr-line><sup>3</sup>Department of Regenerative Dermatology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita-shi, Osaka 565-0871, Japan</addr-line></aff><aff id="aff4"><addr-line><sup>4</sup>Epithelial Cell Biology Laboratory, Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK</addr-line></aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>fiona.watt@cancer.org.uk</email></corresp></author-notes><pub-date pub-type="ppub"><day>08</day><month>5</month><year>2009</year></pub-date><volume>4</volume><issue>5</issue><fpage>427</fpage><lpage>439</lpage><history><date date-type="received"><day>24</day><month>10</month><year>2008</year></date><date date-type="rev-recd"><day>25</day><month>3</month><year>2009</year></date><date date-type="accepted"><day>20</day><month>4</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 ELL &#x00026; Excerpta Medica</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Elsevier Inc.</copyright-holder><license><p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p></license></permissions><abstract><title>Summary</title><p>Lrig1 is a marker of human interfollicular epidermal stem cells and helps maintain stem cell quiescence. We show that, in mouse epidermis, Lrig1 defines the hair follicle junctional zone adjacent to the sebaceous glands and infundibulum. <italic>Lrig1</italic> is a Myc target gene; loss of <italic>Lrig1</italic> increases the proliferative capacity of stem cells in culture and results in epidermal hyperproliferation in&#x000a0;vivo. Lrig1-expressing cells can give rise to all of the adult epidermal lineages in skin reconstitution assays. However, during homeostasis and on retinoic acid stimulation, they are bipotent, contributing to the sebaceous gland and interfollicular epidermis. &#x003b2;-catenin activation increases the size of the junctional zone compartment, and loss of <italic>Lrig1</italic> causes a selective increase in &#x003b2;-catenin-induced ectopic hair follicle formation in the interfollicular epidermis. Our results suggest that <italic>Lrig1</italic>-positive cells constitute a previously unidentified reservoir of adult mouse interfollicular epidermal stem cells.</p></abstract><kwd-group><kwd>STEMCELL</kwd></kwd-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Homeostasis in adult tissues requires balanced proliferation and differentiation. In many cases, this depends on resident stem cells that self-renew and produce the appropriate differentiated lineages of the tissue (<xref rid="bib34" ref-type="bibr">Morrison and Spradling, 2008</xref>). Stem cells reside in unique microenvironments, niches, that are required to maintain the cells' unique properties (<xref rid="bib10 bib47" ref-type="bibr">Fuchs et&#x000a0;al., 2004; Watt and Hogan, 2000</xref>).</p><p>Mammalian epidermis comprises the interfollicular epidermis (IFE) with associated hair follicles (HF), sebaceous glands (SG), and sweat glands. There are believed to be distinct populations of stem cells in different locations. The lineages that they feed are normally constrained by signals from their local environment, but they can give rise to all epidermal lineages in response to appropriate stimuli (<xref rid="bib5 bib24 bib37" ref-type="bibr">Chuong, 2007; Jones et&#x000a0;al., 2007; Owens and Watt, 2003</xref>).</p><p>In human IFE, clusters of stem cells have been identified on the basis of long-term self-renewal ability in culture and quiescence in&#x000a0;vivo; these cells express a range of markers, including high levels of &#x003b2;1 integrins (<xref rid="bib11 bib46" ref-type="bibr">Gambardella and Barrandon, 2003; Watt, 2002</xref>). In contrast, in mouse epidermis, the best characterized stem cell population is in a region of the HF known as the bulge; these cells express keratin 15, CD34, and LGR5 and include a subpopulation of infrequently dividing, DNA label-retaining cells (LRC) (<xref rid="bib8 bib21 bib28 bib42" ref-type="bibr">Cotsarelis et&#x000a0;al., 1990; Jaks et&#x000a0;al., 2008; Liu et&#x000a0;al., 2003; Trempus et&#x000a0;al., 2003</xref>). Recent lineage tracing has established that mouse IFE can be temporarily reconstituted from bulge stem cells (<xref rid="bib19 bib27" ref-type="bibr">Ito et&#x000a0;al., 2005; Levy et&#x000a0;al., 2007</xref>) but is maintained by actively cycling cells that divide or differentiate according to stochastic principles (<xref rid="bib6" ref-type="bibr">Clayton et&#x000a0;al., 2007</xref>). Thus, the mouse IFE stem cell compartment has proved elusive.</p><p>In a screen for human epidermal stem cell markers, we identified Leucine-rich repeats and immunoglobulin-like domain protein 1 (LRIG1) (<xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>). LRIG1 is a transmembrane protein that interacts with and decreases signaling by ErbB growth factor receptors (<xref rid="bib13 bib22 bib26" ref-type="bibr">Gur et&#x000a0;al., 2004; Jensen and Watt, 2006; Laederich et&#x000a0;al., 2004</xref>).</p><p>Expression of Lrig1 is required for epidermal homeostasis, as genetic deletion of <italic>Lrig1</italic> leads to epidermal hyperplasia in mouse skin (<xref rid="bib40" ref-type="bibr">Suzuki et&#x000a0;al., 2002</xref>). Knockdown of <italic>Lrig1</italic> in cultured human keratinocytes causes increased proliferation associated with stem cell expansion (<xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>). In cultured keratinocytes, LRIG1 negatively regulates EGF-induced ERK MAPK signaling and decreases <italic>cMyc</italic> transcription, RNA, and protein levels (<xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>). Because epidermal overexpression of Myc can stimulate both proliferation and terminal differentiation (<xref rid="bib1 bib44" ref-type="bibr">Arnold and Watt, 2001; Waikel et&#x000a0;al., 2001</xref>), it has been proposed that Myc-induced differentiation acts as a fail-safe device to prevent uncontrolled proliferation of stem cells (<xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>).</p><p>We have now examined Lrig1 expression and function in mouse epidermis. We report that Lrig1 expression defines a previously uncharacterized multipotent stem cell population, which normally contributes to the IFE and SG lineages.</p></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>Lrig1 Expression Specifies a Unique Population of Epidermal Cells during Development</title><p>At E14.5, prior to HF placode formation, Lrig1 was expressed at low levels in dorsal epidermis and at higher levels by&#x000a0;a subpopulation of dermal cells (<xref rid="app2" ref-type="sec">Figure&#x000a0;S1</xref>A available online). At E17.5 and E18.5, Lrig1 expression was upregulated in the P-cadherin dim population of multipotent stem cells in the developing HF (<xref rid="bib36" ref-type="bibr">Nowak et&#x000a0;al., 2008</xref>) and was absent from the P-cadherin bright cells at the base (<xref rid="fig1" ref-type="fig">Figures 1</xref>A, <xref rid="app2" ref-type="sec">S1</xref>B, and S1F&#x02013;S1H). Thus, during development, the presumptive bulge stem cell population expressed Lrig1. This expression pattern persisted at P1, except that from then onward, dermal expression was reduced (<xref rid="app2" ref-type="sec">Figure&#x000a0;S1</xref>C). Q-PCR of RNA isolated from back skin samples (<xref rid="app2" ref-type="sec">Figure&#x000a0;S1</xref>D) revealed that <italic>Lrig1</italic> levels peaked at P1.</p><p>In whole mounts of tail epidermis (<xref rid="bib4" ref-type="bibr">Braun et&#x000a0;al., 2003</xref>), the distinct location of the Lrig1-positive population was visualized readily at P1 and P5. &#x003b2;1 integrin is highly expressed by the developing hair follicle stem cell population, expression extending distally from the bulge to the HF bulb (<xref rid="fig1" ref-type="fig">Figures 1</xref>B and <xref rid="app2" ref-type="sec">S1</xref>E). Lrig1-expressing cells in the upper part of the follicle expressed low levels of &#x003b2;1 integrins. By P5, tail epidermal sebaceous glands start to develop; they arose from the Lrig1-positive region of the HF and were themselves Lrig1 positive (<xref rid="app2" ref-type="sec">Figure&#x000a0;S1</xref>E, asterisk).</p></sec><sec id="sec2.2"><title>Lrig1 Expression Defines a Distinct Population of Cells in Adult Epidermis</title><p>In adult telogen back and tail epidermis (resting phase of the hair growth cycle), Lrig1 expression defined a distinct population of cells at the junction between the infundibulum and the SG (<xref rid="fig1" ref-type="fig">Figures 1</xref>C&#x02013;1F), but Lrig1 was no longer detectable in the SG (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C). Lrig1 is the first reported marker of the junctional zone between the HF bulge, SG, and infundibulum (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>I).</p><p>Whereas Lrig1-positive cells in the junctional zone were present throughout the hair growth cycle, two additional sites of Lrig1 expression were found exclusively in anagen (growing) follicles. Lrig1-positive cells were detected in the outer-root sheath below the level of the SGs (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>G, bar and asterisk), extending toward the bulge. They were also found in a ring of cells above the bulb (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>G, asterisk and insert).</p><p>Lrig1-expressing cells in adult mouse epidermis were largely quiescent. In anagen, the zone of Lrig1 expression above the bulb separated the highly proliferative bulb cells from the rest of the outer-root sheath (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>G). In the junctional zone of Lrig1-positive cells, there were fewer Ki67-positive cells than in the adjacent SGs (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>H). In late anagen, the Lrig1-positive cells below the level of the SGs included DNA label-retaining cells, another indicator of quiescence (<xref rid="bib4" ref-type="bibr">Braun et&#x000a0;al., 2003</xref>; <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A).</p><p>We compared Lrig1 expression in telogen epidermis with expression of markers previously reported to define bulge stem cells (CD34, Keratin 15, high levels of &#x003b1;6 integrin) (<xref rid="bib32 bib41 bib42" ref-type="bibr">Lyle et&#x000a0;al., 1998; Tani et&#x000a0;al., 2000; Trempus et&#x000a0;al., 2003</xref>). Lrig1-positive cells expressed high levels of &#x003b1;6 integrin (<xref rid="fig1" ref-type="fig">Figures 1</xref>D&#x02013;1F) but were negative for CD34 (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B). They lacked Keratin 15 (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C) and expressed low levels of Sca1, which is highly expressed in the infundibulum and IFE (<xref rid="bib23" ref-type="bibr">Jensen et&#x000a0;al., 2008</xref>; <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D).</p></sec><sec id="sec2.3"><title>Isolation of Lrig1-Expressing Cells</title><p>To test the ability of Lrig1-positive cells to self-renew and contribute to different epidermal lineages, we used flow cytometry to isolate cells expressing Lrig1. The Lrig1 extracellular domain is sensitive to the trypsinization conditions normally used to disaggregate epidermal cells; however, the Lrig1 epitope was retained when cells were disaggregated with thermolysin (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>E and data not shown). When disaggregated epidermal cells were double-labeled with antibodies to &#x003b1;6 integrin and Lrig1, the Lrig1-positive population had high &#x003b1;6 levels (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>E), consistent with the immunolocalization data (<xref rid="fig1" ref-type="fig">Figures 1</xref>C&#x02013;1E). The specificity of Lrig1 labeling was demonstrated by frozen section and whole-mount immunostaining and flow cytometry of cells from <italic>Lrig1</italic>-null mice (Figures <xref rid="fig1" ref-type="fig">1</xref>C, 1F, and <xref rid="fig2" ref-type="fig">2</xref>E). As expected (<xref rid="fig2" ref-type="fig">Figures 2</xref>B and 2D), Lrig1-positive cells lacked CD34 and had low levels of Sca1 (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>E).</p><p>To examine clonal growth capacity, undifferentiated, &#x003b1;6-positive basal cells (low forward and side scatter; all) were sorted into different fractions: &#x003b1;6, CD34 double-positive (CD34&#x0002b;); &#x003b1;6, Lrig1 double-positive (Lrig1&#x0002b;); and &#x003b1;6-positive, CD34, Lrig1 double-negative (CD34-Lrig1&#x02212;) cells (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>F). Only the Lrig1-positive population was enriched for clonal growth ability relative to unselected &#x003b1;6-positive cells (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>F). Thus, Lrig1 expression defines a distinct population of highly clonogenic epidermal cells.</p><p>We next analyzed RNA from flow-sorted cells (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>G). As predicted, Lrig1-expressing cells did not express the bulge markers <italic>CD34</italic> and <italic>Lgr5</italic> (<xref rid="bib21 bib42" ref-type="bibr">Jaks et&#x000a0;al., 2008; Trempus et&#x000a0;al., 2003</xref>). They also lacked hair keratin 6a, a marker of cells in the bulge and outer-root sheath (<xref rid="bib12" ref-type="bibr">Gu and Coulombe, 2007</xref>). Lrig1-positive cells expressed low levels of <italic>Sca1</italic> and the IFE-terminal differentiation marker keratin 10. Lrig1-positive cells were enriched for expression of the putative SG stem cell marker <italic>Blimp1</italic> (<xref rid="bib17 bib30" ref-type="bibr">Horsley et&#x000a0;al., 2006; Lo Celso et&#x000a0;al., 2008</xref>) and had higher <italic>cMyc</italic> expression than did CD34&#x0002b; cells. Thus, Lrig1-expressing cells are transcriptionally distinct from bulge stem cells and committed HF and IFE cells.</p><p>To allow isolation of junctional zone cells from trypsinized and <italic>Lrig1</italic>-null epidermis, we developed a second sorting strategy. Undifferentiated (low forward and side scatter) epidermal keratinocytes were sorted into six distinct populations based on CD34, &#x003b1;6 integrin, and Sca1 expression (<xref rid="bib23" ref-type="bibr">Jensen et&#x000a0;al., 2008</xref>; <xref rid="fig3" ref-type="fig">Figures 3</xref>A&#x02013;3C). Epidermal cells were divided into &#x003b1;6 integrin-high (I in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A) or -low (II in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A) populations (<xref rid="bib2 bib23 bib38" ref-type="bibr">Blanpain et&#x000a0;al., 2004; Jensen et&#x000a0;al., 2008; Silva-Vargas et&#x000a0;al., 2005</xref>). These two populations were each fractionated into three further groups&#x02014;CD34 positive, Sca1 negative (1 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B; 4 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C); CD34 negative, Sca1 negative (2 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B; 5 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C); or CD34 negative, Sca1 positive (3 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B; 6 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C)&#x02014;and RNA was isolated from all six populations. The color coding of the different populations in <xref rid="fig3" ref-type="fig">Figures 3</xref>B and 3C matches the colors in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D. Cells in population 2 were, as expected, enriched for <italic>Lrig1</italic> expression (<xref rid="fig3" ref-type="fig">Figures 3</xref>A&#x02013;3D and <xref rid="app2" ref-type="sec">Figures S2</xref>A&#x02013;S2F) and had the same RNA expression profile as cells sorted with Lrig1 antibodies (<xref rid="app2" ref-type="sec">Figures S2</xref>D&#x02013;S2F; cf. <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>G). We conclude that sorting CD34-negative, Sca1-negative, &#x003b1;6 integrin-high cells represents an alternative strategy for enriching <italic>Lrig1</italic>-positive cells.</p></sec><sec id="sec2.4"><title>Lrig1-Expressing Cells Can Contribute to All Epidermal Lineages</title><p>To examine the capacity of Lrig1-positive cells to generate different epidermal lineages, we isolated cells on the basis of CD34, Sca1, and &#x003b1;6 integrin expression from mice expressing GFP under the control of the <italic>chicken &#x003b2;-actin promoter</italic>. The 10<sup>5</sup> sorted GFP-positive cells were combined with 3 &#x000d7; 10<sup>6</sup> unlabeled, unfractionated epidermal cells from a wild-type (GFP-negative) mouse. The low ratio of GFP-positive to GFP-negative cells allowed subsequent clonal analysis. The disaggregated epidermal cells were combined with P2 dermal cells, injected into a silicone chamber on the back of a nude mouse, and allowed to reconstitute skin for 4&#x02013;5 weeks. We compared bulge cells (CD34 positive, Sca1 negative, &#x003b1;6 high) (population 1 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B) with Lrig1-enriched cells (CD34 negative, Sca1 negative, &#x003b1;6 high) (population 2 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B) and CD34-negative, Sca1-positive, &#x003b1;6-high cells (population 3 in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B), which have previously been reported to be lineage-committed IFE cells (<xref rid="bib23" ref-type="bibr">Jensen et&#x000a0;al., 2008</xref>). We also isolated Lrig1, GFP double-positive cells from thermolysin-treated epidermis using Lrig1 antibodies and combined them with unfractionated, trypsin-disaggregated cells.</p><p>At 4&#x02013;5 weeks postgrafting, grafts were analyzed for the contribution of GFP-positive cells to SGs, HFs, and IFE. When viewed macroscopically from the dermal side, the contribution of all four populations of GFP-positive cells to HFs was evident (<xref rid="fig3" ref-type="fig">Figures 3</xref>E&#x02013;3H). The extent of contribution of each population was similar: 6% &#x000b1; 4% of HFs contained GFP-positive, Lrig1-enriched cells, compared to 1% &#x000b1; 1% for CD34-positive cells and 3% &#x000b1; 1% for Sca1-positive cells (n &#x0003d; 3 &#x000b1; SEM). The number of reconstituted follicles was lower following thermolysin treatment, reflecting decreased cell viability (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>H and data not shown).</p><p>By staining sections with GFP antibodies, we established that all four populations founded IFE clones of varying size and contributed to HFs and SGs (<xref rid="fig3" ref-type="fig">Figures 3</xref>I&#x02013;3P). All HFs and SGs that contained GFP-positive cells also had a contribution of GFP-negative cells (<xref rid="fig3" ref-type="fig">Figures 3</xref>I&#x02013;3L and 3P). None of the sorted populations were restricted in terms of contribution to the different HF lineages (<xref rid="fig3" ref-type="fig">Figures 3</xref>I&#x02013;3L and 3P).</p><p>We conclude that populations of bulge stem cells, Lrig1-positive cells, and the Sca1-positive cells previously reported to be committed IFE cells (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D) all contain multipotent cells that contribute to all lineages in reconstituted epidermis.</p></sec><sec id="sec2.5"><title>Lrig1 Expression Controls Proliferation in the Interfollicular Epidermis</title><p>We next generated <italic>Lrig1</italic>-null mice by breeding heterozygous animals and compared null, heterozygous, and wild-type littermates. We saw no differences between wild-type and heterozygous animals. The tail epidermis of <italic>Lrig1</italic>-null mice was thicker than that of wild-type (<xref rid="fig4" ref-type="fig">Figures 4</xref>A and 4B), and HFs protruded at a greater angle (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and 4D). There was no SG hyperplasia, and the hair growth cycle was not grossly perturbed (<xref rid="fig4" ref-type="fig">Figures 4</xref>A and 4B and data not shown). Expression of Keratin 10 and Keratin 15 was normal (<xref rid="fig4" ref-type="fig">Figures 4</xref>E and 4I and data not shown). As reported previously, Keratin 6 was expressed in <italic>Lrig1</italic>-null IFE, consistent with epidermal hyperproliferation (<xref rid="bib40" ref-type="bibr">Suzuki et&#x000a0;al., 2002</xref>; data not shown). Flow cytometry for Sca1, CD34, and &#x003b1;6 integrin (<xref rid="fig4" ref-type="fig">Figures 4</xref>F and 4J and data not shown) demonstrated that loss of <italic>Lrig1</italic> did not affect the size of any of the six cell populations defined in <xref rid="fig3" ref-type="fig">Figures 3</xref>A&#x02013;3C. Thus, loss of <italic>Lrig1</italic> did not change the size of the bulge stem cell compartment or the population of cells that normally express Lrig1.</p><p>The most striking phenotype was an increase in IFE proliferation. In embryonic and P1 epidermis, the effect was evident in some areas (<xref rid="fig4" ref-type="fig">Figures 4</xref>G and 4K), but the mean data from replicate samples was not statistically significant (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>M). However, in adult skin, there was a marked increase both in Ki67-positive cells and in BrdU-labeled S phase cells (<xref rid="fig4" ref-type="fig">Figures 4</xref>H, 4L, 4M, and data not shown).</p><p>Consistent with increased epidermal proliferation, the number of DNA label-retaining cells in adult <italic>Lrig1</italic>-null epidermis was substantially reduced (<xref rid="fig4" ref-type="fig">Figures 4</xref>N and 4O). This was quantitated by flow cytometric analysis of label-retaining cells in the bulge (CD34 positive, Sca1 negative, &#x003b1;6 high), the cells that would normally express Lrig1 (CD34 negative, Sca1 negative, &#x003b1;6 high), and total undifferentiated epidermal cells (&#x003b1;6 positive) (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>P). The number of label-retaining cells was decreased in all three populations.</p><p>These results demonstrate that Lrig1 is required for stem cell quiescence in adult mouse epidermis, as observed in cultured human epidermis (<xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>).</p></sec><sec id="sec2.6"><title>Lrig1 and cMyc Form an Autoregulatory Feedback Loop</title><p>Activation of Myc in the basal layer of mouse epidermis results in increased proliferation (<xref rid="bib1 bib44" ref-type="bibr">Arnold and Watt, 2001; Waikel et&#x000a0;al., 2001</xref>), whereas, in cultured human epidermal keratinocytes, LRIG1 overexpression decreases Myc levels and reduces proliferation (<xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>). There was upregulation of Myc protein and mRNA in the tail skin of <italic>Lrig1</italic>-null mice (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A). This suggests that the increased proliferation of <italic>Lrig1</italic>-null epidermis is attributable, at least in part, to increased Myc activity.</p><p>To examine whether Myc activation affected <italic>Lrig1</italic> expression, we examined the epidermis of <italic>K14MycER</italic>-transgenic mice following topical application of 4-hydroxy-Tamoxifen (4OHT) (<xref rid="bib1" ref-type="bibr">Arnold and Watt, 2001</xref>). Myc activation resulted in increased <italic>Lrig1</italic> mRNA levels in telogen back skin (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B). There was an increase in Lrig1-expressing cells in the junctional zone, with Lrig1-positive cells extending upwards into the adjacent IFE (<xref rid="fig5" ref-type="fig">Figures 5</xref>D&#x02013;5G).</p><p>Examination of &#x0223c;1.6 kb upstream of the <italic>Lrig1</italic> transcriptional start site revealed several E boxes, including a pair at 1546 and 1391 bp (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>H). When the upstream sequence was coupled to luciferase and transiently transfected into <italic>K14MycER</italic> keratinocytes, we observed a 4OHT concentration-dependent induction of <italic>Lrig1</italic> promoter activity when compared to normal cells (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C).</p><p>Following chromatin immunoprecipitation (ChIP) of cells from 4OHT-treated <italic>K14MycER</italic> back skin, one region of the <italic>Lrig1</italic> promoter containing the two E boxes was specifically enriched in two independent biological replicates (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>I). As a positive control, we confirmed that the promoter of <italic>Nucleolin</italic>, a known Myc target gene, was also enriched in cMyc binding (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>I). A genomic sequence 7 kb downstream of the <italic>Nucleolin</italic> promoter was not bound (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>I, Ctrl). In addition, knockdown of <italic>Myc</italic> expression in primary mouse keratinocytes using RNAi led to a comparable reduction in <italic>Lrig1</italic> expression (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>J).</p><p>We conclude that cMyc positively regulates <italic>Lrig1</italic> and that the two proteins are involved in a feedback loop that controls their expression (<xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>).</p></sec><sec id="sec2.7"><title>Lineage Analysis of Junctional Zone Cells</title><p>The phenotype of <italic>Lrig1</italic>-null epidermis (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>) suggested that, although Lrig1-positive cells could contribute to all of the epidermal lineages in skin reconstitution assays (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>), their role in epidermal homeostasis might be to maintain the IFE. To investigate this, we exploited the low stochastic leakiness associated with <italic>Keratin 14</italic> promoter-driven CreER recombination events (<xref rid="bib15 bib43" ref-type="bibr">Hong et&#x000a0;al., 2004; Vasioukhin et&#x000a0;al., 1999</xref>). <italic>K14CreER</italic> mice were crossed with <italic>CAG-CAT-eGFP</italic> (<italic>stop-flox-GFP</italic>) mice (<xref rid="bib25" ref-type="bibr">Kawamoto et&#x000a0;al., 2000</xref>), in which Cre-mediated recombination results in GFP expression in the descendents of each cell in which the recombination event occurred (<xref rid="bib3" ref-type="bibr">Bleul et&#x000a0;al., 2006</xref>; <xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A). Recombination mainly occurs postnatally, and from 3&#x000a0;months, epidermal GFP-positive clones are readily detectable.</p><p>It has previously been reported that, under steady-state conditions, the IFE is primarily maintained by committed progenitors located within the IFE; however, any contribution of cells in the junctional zone or infundibulum was excluded from the analysis (<xref rid="bib6" ref-type="bibr">Clayton et&#x000a0;al., 2007</xref>). In back skin from 4-month-old <italic>K14CreER</italic> &#x000d7; <italic>stop-flox-GFP</italic> animals, clones of GFP-expressing cells were detected in all epidermal regions: junctional zone, infundibulum, IFE, SG, and HF. The clones of GFP cells in the junctional zone (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>B) occasionally extended into the infundibulum and IFE (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C). To examine the response of the junctional zone population to increased IFE proliferation, we treated <italic>K14CreER</italic> &#x000d7; <italic>stop-flox-GFP</italic> mice with all-trans retinoic acid (ATRA) for 4&#x000a0;days, which preferentially stimulates IFE proliferation (<xref rid="bib7" ref-type="bibr">Collins and Watt, 2008</xref>; data not shown).</p><p>Three-dimensional reconstructions of epidermal whole mounts were analyzed with Volocity software. The size (volume) of individual GFP clones located in the junctional zone (n &#x0003d; 85 in control [ctrl] epidermis; n &#x0003d; 161 in ATRA-treated epidermis), IFE (n &#x0003d; 1184 ctrl, 1525 ATRA), infundibulum (n &#x0003d; 81 ctrl, 152 ATRA), SG (n &#x0003d; 53 ctrl, 80 ATRA), and HF (n &#x0003d; 65 ctrl, 293 ATRA) was determined, and the cumulative frequency distribution of clone sizes was plotted (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>E). In control epidermis, the median clone size (50% ranking in <xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>E; &#x0201c;&#x0002b;&#x0201d; in <xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>H) was similar in IFE, HF, junctional zone, and infundibulum but significantly smaller in the SG (p &#x0003c; 0.05, two-tailed unpaired Mann-Whitney test).</p><p>The only category of clone to enlarge significantly upon ATRA treatment was that originating in the junctional zone (<xref rid="fig6" ref-type="fig">Figures 6</xref>D and 6H; p &#x0003c; 0.05; Mann-Whitney two-tailed unpaired test). The increase was observed for all clone sizes falling between the 25th and 100th percentile (25%&#x02013;100% ranking in <xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>E). ATRA treatment also resulted in the enlargement of junctional zone clones compared with ATRA-treated clones in the IFE, infundibulum, SG, and HF (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>H; p &#x0003c; 0.05). Both before and after ATRA treatment, junctional zone clones contributed cells to the infundibulum, IFE, and SG, but not to the HF below the SG (<xref rid="fig6" ref-type="fig">Figures 6</xref>F and 6G). Conversely, HF clones never contributed to the junctional zone.</p><p>These results indicate that, although Lrig1-positive cells give rise to HF lineages in skin reconstitution assays (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>), they are bipotent in intact skin (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>D). In response to an IFE proliferative stimulus, there is selective expansion of junctional zone clones into the IFE and SG (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>D).</p></sec><sec id="sec2.8"><title>Loss of <italic>Lrig1</italic> Results in Expansion of the Junctional Zone Stem Cell Compartment and Increased &#x003b2;-Catenin Responsiveness</title><p>To examine the effects of <italic>Lrig1</italic> loss on keratinocyte growth in culture, we performed clonal growth assays on the six epidermal populations sorted on the basis of CD34, Sca1, and &#x003b1;6 expression from the back skin of telogen mice (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>A). There was an increase in the colony-forming efficiency of each population and also of total basal cells (all: &#x003b1;6 positive, low forward, and side scatter). This is consistent with expression of <italic>Lrig1</italic> in all subpopulations of cells, albeit at different levels (<xref rid="app2" ref-type="sec">Figure&#x000a0;S2</xref>E), and with upregulation of cMyc in cultured keratinocytes (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref> and data not shown). However, the increase was most dramatic in the CD34-negative, Sca1-negative, &#x003b1;6 integrin-high population, the cells that normally are highly enriched for <italic>Lrig1</italic> expression. We conclude that, in the absence of Lrig1, this population of cells has a selective growth advantage.</p><p>The expansion of clonal growth on loss of <italic>Lrig1</italic> is reminiscent of the effects of activating &#x003b2;-catenin (<xref rid="bib38" ref-type="bibr">Silva-Vargas et&#x000a0;al., 2005</xref>). Therefore, we examined Lrig1 expression in <italic>K14&#x00394;N&#x003b2;-cateninER</italic>-transgenic mice, in which &#x003b2;-catenin is activated by 4OHT treatment (<xref rid="bib29 bib38" ref-type="bibr">Lo Celso et&#x000a0;al., 2004; Silva-Vargas et&#x000a0;al., 2005</xref>). &#x003b2;-catenin activation resulted in an increase in Lrig1-positive cells in the junctional zone and adjacent IFE (<xref rid="fig7" ref-type="fig">Figures 7</xref>B and 7C), as observed in <italic>K14MycER</italic> mice (<xref rid="fig5" ref-type="fig">Figures 5</xref>F and 5G). Lrig1 was also expressed in ectopic follicles (<xref rid="fig7" ref-type="fig">Figures 7</xref>C, arrow and insert). There was a 2-fold increase in the &#x003b1;6 integrin-high, Lrig1-positive population (<xref rid="fig7" ref-type="fig">Figures 7</xref>D and 7E) and a 4-fold increase in the CD34-negative, Sca1-negative, &#x003b1;6-high population (population 2 in <xref rid="app2" ref-type="sec">Figures S2</xref>G and S2H).</p><p>Q-PCR analysis showed an increase in <italic>Lrig1</italic> mRNA in response to &#x003b2;-catenin (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>F). However, 5 kb upstream of the <italic>Lrig1</italic> transcription start site did not contain TCF- and Lef-binding sites, and Lrig1 expression was unaffected when &#x003b2;-catenin signaling was blocked with an N terminally truncated Lef1 transgene (data not shown). <italic>Lrig1</italic> expression was not induced in keratinocytes by Wnt3A under conditions in which known target genes, <italic>Axin2</italic> and <italic>Jagged1</italic> (<xref rid="bib9 bib31" ref-type="bibr">Estrach et&#x000a0;al., 2006; Lustig et&#x000a0;al., 2002</xref>), were induced (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>G). In contrast, <italic>cMyc</italic>, a known target of &#x003b2;-catenin (<xref rid="bib14" ref-type="bibr">He et&#x000a0;al., 1998</xref>) was upregulated upon activation of &#x003b2;-catenin (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>F). Moreover, upon &#x003b2;-catenin activation, there was a substantial increase in the amount of endogenous Myc associated with the E boxes on the <italic>Lrig1</italic> promoter (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>H). We conclude that, upon &#x003b2;-catenin activation, the Lrig1-positive compartment expands, but this reflects upregulation of cMyc because <italic>Lrig1</italic> expression is not directly regulated by &#x003b2;-catenin.</p><p>To examine the consequences of loss of <italic>Lrig1</italic> on &#x003b2;-catenin activation, we crossed <italic>K14&#x00394;N&#x003b2;-cateninER</italic> mice with <italic>Lrig1</italic>-null mice and examined adult tail epidermis following 4OHT treatment. On a wild-type background, 4OHT treatment induces ectopic HFs in the IFE, SGs, and existing follicles (<xref rid="bib38" ref-type="bibr">Silva-Vargas et&#x000a0;al., 2005</xref>). Activation of &#x003b2;-catenin in the absence of <italic>Lrig1</italic> caused expansion of the junctional zone and a selective increase in ectopic follicles in the IFE, particularly in the vicinity of the junctional zone (<xref rid="fig7" ref-type="fig">Figures 7</xref>I and 7J). <italic>Lrig1</italic> loss led to some SG enlargement on &#x003b2;-catenin activation, but there was no increase in the number of ectopic follicles arising from the SG or existing follicles (<xref rid="fig7" ref-type="fig">Figures 7</xref>I, 7J, 7L, and 7M).</p><p>In addition to quantitating the ectopic follicles per unit length of IFE (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>K), we scored epithelial cell clusters expressing CDP, an early marker of ectopic follicle formation (<xref rid="bib38" ref-type="bibr">Silva-Vargas et&#x000a0;al., 2005</xref>) (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>N). There was an increase in CDP-positive clusters, irrespective of cluster size (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>N). Thus, <italic>Lrig1</italic> loss affects ectopic follicle number rather than size.</p><p>We conclude that activation of &#x003b2;-catenin in the absence of <italic>Lrig1</italic> causes an increase in the number of junctional zone stem cells and that they can form ectopic HF.</p></sec></sec><sec id="sec3"><title>Discussion</title><p>We have defined a distinct population of multipotent stem cells in the junctional zone of the HF that expresses Lrig1. In epidermal reconstitution experiments, these cells contribute as effectively as bulge stem cells to all of the epidermal lineages. However, lineage analysis suggests that they are bipotent in steady-state epidermis, giving rise to cells in the IFE and SG.</p><p>It has been reported that, during normal epidermal homeostasis, the IFE can be maintained by committed progenitors (<xref rid="bib6" ref-type="bibr">Clayton et&#x000a0;al., 2007</xref>). Following wounding, bulge stem cells contribute only transiently to the IFE (<xref rid="bib19" ref-type="bibr">Ito et&#x000a0;al., 2005</xref>), whereas cells originating above the bulge stem cell compartment or in the infundibulum contribute long-term (<xref rid="bib27" ref-type="bibr">Levy et&#x000a0;al., 2007</xref>). Several lines of evidence suggest that the junctional zone constitutes this previously unidentified reservoir of IFE stem cells. Lineage tracing demonstrates that cells in the junctional zone contribute to the infundibulum, SG, and, occasionally, the IFE. In response to ATRA, which causes IFE proliferation, there is selective expansion of junctional zone clones into these compartments. Moreover, activation of &#x003b2;-catenin causes a marked increase in the size of the junctional zone compartment. In <italic>Lrig1</italic>-null epidermis, this expansion is associated with a corresponding increase in the number of ectopic HFs that form specifically in the IFE adjacent to the infundibulum, but not elsewhere. This cannot simply be due to increased IFE proliferation in <italic>Lrig1</italic>-null epidermis because ATRA treatment, which stimulates IFE proliferation, does not affect &#x003b2;-catenin-induced ectopic HF formation (<xref rid="bib7" ref-type="bibr">Collins and Watt, 2008</xref>; C.A.C. and F.M.W., unpublished data).</p><p>The Lrig1-positive population is specified early in development, coinciding with the formation of the HF stem cell niche (<xref rid="bib36" ref-type="bibr">Nowak et&#x000a0;al., 2008</xref>), and persists during adulthood. Lrig1-expressing stem cells can be isolated directly via Lrig1 or enriched on the basis of high &#x003b1;6 integrin expression and lack of CD34 and Sca1. Cells that express Lrig1 are negative for the bulge markers keratin 6a, keratin 15, CD34, and Lgr5 (<xref rid="bib28 bib42 bib21" ref-type="bibr">Liu et&#x000a0;al., 2003; Trempus et&#x000a0;al., 2003; Jaks et&#x000a0;al., 2008</xref>). They show elevated expression of <italic>Blimp1</italic>, a previously reported marker of SG stem cells (<xref rid="bib17" ref-type="bibr">Horsley et&#x000a0;al., 2006</xref>), and of the <italic>Lgr</italic> family member <italic>Lgr6</italic> (<xref rid="bib18" ref-type="bibr">Hsu et&#x000a0;al., 2000</xref>). Expression of <italic>MTS24/Plet1</italic>, which is reported to be a marker of Sca1-negative, CD34-negative keratinocytes (<xref rid="bib23 bib35" ref-type="bibr">Jensen et&#x000a0;al., 2008; Nijhof et&#x000a0;al., 2006</xref>), was not specifically upregulated in Lrig1-expressing cells. Lrig1 is the first marker of the junctional zone to be described, and cells in this region have a unique gene expression profile.</p><p>Lrig1 was originally identified as a human IFE stem cell marker that keeps cells in a quiescent, nondividing state (<xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>). Consistent with those observations, loss of <italic>Lrig1</italic> in mouse epidermis resulted in hyperproliferation in the IFE. <italic>Lrig1</italic> loss did not affect the HFs or SGs. In contrast, loss of the transcriptional repressor <italic>Blimp1</italic> selectively induces excessive proliferation in the SG (<xref rid="bib17" ref-type="bibr">Horsley et&#x000a0;al., 2006</xref>), whereas loss of <italic>NFATc1</italic> causes continuous HF cycling (<xref rid="bib16" ref-type="bibr">Horsley et&#x000a0;al., 2008</xref>). Loss of <italic>Lrig1</italic>, <italic>Blimp1</italic>, or <italic>NFATc1</italic> is characterized by reduction in the number of LRCs as they are recruited into the cell cycle. Thus, it appears that these three proteins function in concert to maintain quiescence in different epidermal stem cell compartments.</p><p>We found that Lrig1 and Myc participate in an autoregulatory feedback loop; cMyc regulates transcription of the <italic>Lrig1</italic> gene, and Lrig1 negatively regulates Myc expression (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>; <xref rid="bib22" ref-type="bibr">Jensen and Watt, 2006</xref>). It has also been shown that Blimp1 is a direct negative regulator of Myc (<xref rid="bib17" ref-type="bibr">Horsley et&#x000a0;al., 2006</xref>). This may explain why ectopic activation of Myc under the control of the keratin 14 promoter causes hyperplasia of both IFE and SG (<xref rid="bib1 bib44" ref-type="bibr">Arnold and Watt, 2001; Waikel et&#x000a0;al., 2001</xref>), whereas loss of <italic>Lrig1</italic> specifically affects the IFE. It is interesting that Myc is required for anagen entry (<xref rid="bib39" ref-type="bibr">Soucek et&#x000a0;al., 2008</xref>) because this coincides with the appearance of the ring of Lrig1-positive cells above the HF bulb (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>G).</p><p>In epidermal reconstitution experiments, Lrig1-enriched cells and Lrig1-positive cells were as effective as bulge cells in contributing to the different epidermal lineages. Surprisingly, Sca1-positive cells, previously reported to be committed progenitors of the IFE (<xref rid="bib23" ref-type="bibr">Jensen et&#x000a0;al., 2008</xref>), were also capable of contributing to HFs and SGs. We suggest that the behavior of cells in different regions of the epidermis is normally constrained by signals from their local environment (<xref rid="bib37" ref-type="bibr">Owens and Watt, 2003</xref>). However, most, if not all, epidermal cells that are competent to proliferate will exhibit multilineage differentiation potential when challenged genetically (<xref rid="bib38" ref-type="bibr">Silva-Vargas et&#x000a0;al., 2005</xref>), by wounding (<xref rid="bib20" ref-type="bibr">Ito et&#x000a0;al., 2007</xref>), or in epidermal reconstitution experiments. This would certainly be consistent with recent observations on the properties of cells from different regions of the ocular surface (<xref rid="bib33" ref-type="bibr">Majo et&#x000a0;al., 2008</xref>). Important questions for the future are whether all of the different epidermal stem cell populations arise from the P-cadherin-low, Lrig1-positive cells in developing HFs and whether the different stem cell populations in adult epidermis have a hierarchical relationship or are completely autonomous.</p></sec><sec sec-type="materials-methods" id="sec4"><title>Experimental Procedures</title><sec id="sec4.1"><title>Mice and Labeling Experiments</title><p><italic>Lrig1</italic>-null (<xref rid="bib40" ref-type="bibr">Suzuki et&#x000a0;al., 2002</xref>), <italic>K14MycER</italic> (<xref rid="bib1" ref-type="bibr">Arnold and Watt, 2001</xref>), <italic>K14&#x00394;N-&#x003b2;-cateninER</italic> (line D2) (<xref rid="bib29" ref-type="bibr">Lo Celso et&#x000a0;al., 2004</xref>), <italic>K14CreER</italic> (<xref rid="bib15" ref-type="bibr">Hong et&#x000a0;al., 2004</xref>; kind gift from B. Stripp), <italic>CAG-CAT-eGFP</italic> (<xref rid="bib25" ref-type="bibr">Kawamoto et&#x000a0;al., 2000</xref>; kind gift from J. Miyazaki), and <italic>&#x003b2;-actin-eGFP</italic> (C57BL/6 jax strain, stock number: 003291) mice have been described previously. In some experiments, mice were treated with 4-hydroxy-Tamoxifen (4OHT) at a concentration of 1.5&#x000a0;mg/200 &#x003bc;l in acetone three times a week on the back and tail. Some mice were treated with 100 &#x003bc;l 0.5mM ATRA (Sigma) in acetone on back and tail as described (<xref rid="bib7" ref-type="bibr">Collins and Watt, 2008</xref>). DNA label-retaining cells were generated by repeated BrdU injections of neonatal mice, as described previously (<xref rid="bib4" ref-type="bibr">Braun et&#x000a0;al., 2003</xref>).</p></sec><sec id="sec4.2"><title>Flow Cytometry</title><p>Keratinocytes were isolated from telogen dorsal back skin using either trypsin as described (<xref rid="bib38" ref-type="bibr">Silva-Vargas et&#x000a0;al., 2005</xref>) or thermolysin (<xref rid="bib45" ref-type="bibr">Walzer et&#x000a0;al., 1989</xref>). To isolate epidermal cells using thermolysin, we rinsed back skin in 10% Betadine and 70% ethanol and washed it in PBS. The dermal side was thoroughly scraped to remove excess fat, and then the tissue was floated in 0.25 mg/ml Thermolysin (Sigma) in calcium-free FAD medium for 1 hr at 37&#x000b0;C. The epidermis was subsequently scraped from the dermis, minced with scalpels, and disaggregated by gentle pipetting. Thermolysin was inactivated by addition of FCS, and the cells were pelleted and resuspended for labeling with antibodies (see <xref rid="app2" ref-type="sec">Supplemental Data</xref>). Cell sorting was carried out using a MoFlo high-speed sorter (Dako Cytomation), and analysis was carried out on a CyAN ADP analyzer (Dako Cytomation). All data analysis was conducted using the FlowJo program.</p></sec><sec id="sec4.3"><title>Hair Reconstitution Assays</title><p>The experiments were performed essentially as described previously (<xref rid="bib23" ref-type="bibr">Jensen et&#x000a0;al., 2008</xref>). Each graft consisted of 10<sup>5</sup> GFP-expressing epidermal cells mixed with 3 &#x000d7; 10<sup>6</sup> unlabeled, unsorted epidermal cells and 5 &#x000d7; 10<sup>6</sup> dermal cells isolated from neonatal fibroblasts. We typically isolated 10<sup>5</sup> cells per mouse of Lrig1-positive cells or the two groups of &#x003b1;6 integrin-high, Sca1-negative cells. The tops of the graft chambers were removed 1 week after grafting, and the chambers were removed 1 week later. Hair growth was typically observed 1 week after chamber removal. Mice were sacrificed and analyzed 4&#x02013;5 weeks postgrafting.</p></sec><sec id="sec4.4"><title>Mouse Keratinocyte Culture</title><p>Mouse keratinocytes were isolated and cultured on a J2 3T3 feeder layer as described (<xref rid="bib38" ref-type="bibr">Silva-Vargas et&#x000a0;al., 2005</xref>). For clonal growth assays, 600 to 2500 cells were plated per well in 6-well plates and cultured for 2 weeks prior to fixation and staining with 1% Rhodamine B.</p></sec><sec id="sec4.5"><title>Statistical Analysis</title><p>The significance of quantitative data was tested using the unpaired, two-tailed Student's t test. Data from the lineage analysis experiments were analyzed using an unpaired, two-tailed Mann-Whitney test.</p></sec></sec><sec id="app1" sec-type="supplementary-material"><title>Supplemental Data</title><p>The Supplemental Data include Supplemental Experimental Procedures and two figures and can be found with this article online at <ext-link xlink:href="http://www.cell.com/cell-stem-cell/supplemental/S1934-5909(09)00168-4" ext-link-type="uri">http://www.cell.com/cell-stem-cell/supplemental/S1934-5909(09)00168-4</ext-link>.</p></sec><sec id="app2" sec-type="supplementary-material"><title>Supplemental Data</title><p><supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Supplemental Experimental Procedures and Two Figures</title></caption><media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Angela Mowbray, Peter Humphreys, Rachael Walker, and Margaret MacLeish for expert technical assistance. We are grateful to Duncan Odom, David Owens, David Doup&#x000e9;, Phil Jones, Ryan Driskell, Adam Giangreco, Hironobu Fujiwara, Esther Arwert, and the entire Watt lab for suggestions and advice. This work was supported by Cancer Research UK, the Medical Research Council, the Wellcome Trust, and EuroStemCell. We are also grateful for support from the University of Cambridge and Hutchison Whampoa Ltd. K.B.J. is a Carlsberg Fellow. C.A.C. is a Herchel Smith postdoctoral fellow and the recipient of an Evans-Freke Next Generation Junior Research Fellowship. D.W.T. is supported by A<sup>&#x02217;</sup>STAR, Singapore.</p></ack><ref-list><title>References</title><ref id="bib1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>I.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny</article-title><source>Curr. Biol.</source><year>2001</year><volume>11</volume><fpage>558</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">11369200</pub-id></citation></ref><ref id="bib2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanpain</surname><given-names>C.</given-names></name><name><surname>Lowry</surname><given-names>W.E.</given-names></name><name><surname>Geoghegan</surname><given-names>A.</given-names></name><name><surname>Polak</surname><given-names>L.</given-names></name><name><surname>Fuchs</surname><given-names>E.</given-names></name></person-group><article-title>Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>635</fpage><lpage>648</lpage><pub-id pub-id-type="pmid">15339667</pub-id></citation></ref><ref id="bib3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bleul</surname><given-names>C.C.</given-names></name><name><surname>Corbeaux</surname><given-names>T.</given-names></name><name><surname>Reuter</surname><given-names>A.</given-names></name><name><surname>Fisch</surname><given-names>P.</given-names></name><name><surname>Monting</surname><given-names>J.S.</given-names></name><name><surname>Boehm</surname><given-names>T.</given-names></name></person-group><article-title>Formation of a functional thymus initiated by a postnatal epithelial progenitor cell</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>992</fpage><lpage>996</lpage><pub-id pub-id-type="pmid">16791198</pub-id></citation></ref><ref id="bib4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>K.M.</given-names></name><name><surname>Niemann</surname><given-names>C.</given-names></name><name><surname>Jensen</surname><given-names>U.B.</given-names></name><name><surname>Sundberg</surname><given-names>J.P.</given-names></name><name><surname>Silva-Vargas</surname><given-names>V.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Manipulation of stem cell proliferation and lineage commitment: Visualisation of label-retaining cells in wholemounts of mouse epidermis</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>5241</fpage><lpage>5255</lpage><pub-id pub-id-type="pmid">12954714</pub-id></citation></ref><ref id="bib5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chuong</surname><given-names>C.M.</given-names></name></person-group><article-title>Regenerative biology: New hair from healing wounds</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>265</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">17507966</pub-id></citation></ref><ref id="bib6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>E.</given-names></name><name><surname>Doup&#x000e9;</surname><given-names>D.P.</given-names></name><name><surname>Klein</surname><given-names>A.M.</given-names></name><name><surname>Winton</surname><given-names>D.J.</given-names></name><name><surname>Simons</surname><given-names>B.D.</given-names></name><name><surname>Jones</surname><given-names>P.H.</given-names></name></person-group><article-title>A single type of progenitor cell maintains normal epidermis</article-title><source>Nature</source><year>2007</year><volume>446</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">17330052</pub-id></citation></ref><ref id="bib7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>C.A.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling</article-title><source>Dev. Biol.</source><year>2008</year><volume>324</volume><fpage>55</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">18805411</pub-id></citation></ref><ref id="bib8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cotsarelis</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>T.T.</given-names></name><name><surname>Lavker</surname><given-names>R.M.</given-names></name></person-group><article-title>Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis</article-title><source>Cell</source><year>1990</year><volume>61</volume><fpage>1329</fpage><lpage>1337</lpage><pub-id pub-id-type="pmid">2364430</pub-id></citation></ref><ref id="bib9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Estrach</surname><given-names>S.</given-names></name><name><surname>Ambler</surname><given-names>C.A.</given-names></name><name><surname>Lo Celso</surname><given-names>C.</given-names></name><name><surname>Hozumi</surname><given-names>K.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in adult epidermis</article-title><source>Development</source><year>2006</year><volume>133</volume><fpage>4427</fpage><lpage>4438</lpage><pub-id pub-id-type="pmid">17035290</pub-id></citation></ref><ref id="bib10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>E.</given-names></name><name><surname>Tumbar</surname><given-names>T.</given-names></name><name><surname>Guasch</surname><given-names>G.</given-names></name></person-group><article-title>Socializing with the neighbors: Stem cells and their niche</article-title><source>Cell</source><year>2004</year><volume>116</volume><fpage>769</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">15035980</pub-id></citation></ref><ref id="bib11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gambardella</surname><given-names>L.</given-names></name><name><surname>Barrandon</surname><given-names>Y.</given-names></name></person-group><article-title>The multifaceted adult epidermal stem cell</article-title><source>Curr. Opin. Cell Biol.</source><year>2003</year><volume>15</volume><fpage>771</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">14644204</pub-id></citation></ref><ref id="bib12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>L.H.</given-names></name><name><surname>Coulombe</surname><given-names>P.A.</given-names></name></person-group><article-title>Keratin expression provides novel insight into the morphogenesis and function of the companion layer in hair follicles</article-title><source>J.&#x000a0;Invest. Dermatol.</source><year>2007</year><volume>127</volume><fpage>1061</fpage><lpage>1073</lpage><pub-id pub-id-type="pmid">17170733</pub-id></citation></ref><ref id="bib13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gur</surname><given-names>G.</given-names></name><name><surname>Rubin</surname><given-names>C.</given-names></name><name><surname>Katz</surname><given-names>M.</given-names></name><name><surname>Amit</surname><given-names>I.</given-names></name><name><surname>Citri</surname><given-names>A.</given-names></name><name><surname>Nilsson</surname><given-names>J.</given-names></name><name><surname>Amariglio</surname><given-names>N.</given-names></name><name><surname>Henriksson</surname><given-names>R.</given-names></name><name><surname>Rechavi</surname><given-names>G.</given-names></name><name><surname>Hedman</surname><given-names>H.</given-names></name></person-group><article-title>LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation</article-title><source>EMBO J.</source><year>2004</year><volume>23</volume><fpage>3270</fpage><lpage>3281</lpage><pub-id pub-id-type="pmid">15282549</pub-id></citation></ref><ref id="bib14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>T.C.</given-names></name><name><surname>Sparks</surname><given-names>A.B.</given-names></name><name><surname>Rago</surname><given-names>C.</given-names></name><name><surname>Hermeking</surname><given-names>H.</given-names></name><name><surname>Zawel</surname><given-names>L.</given-names></name><name><surname>da Costa</surname><given-names>L.T.</given-names></name><name><surname>Morin</surname><given-names>P.J.</given-names></name><name><surname>Vogelstein</surname><given-names>B.</given-names></name><name><surname>Kinzler</surname><given-names>K.W.</given-names></name></person-group><article-title>Identification of c-MYC as a target of the APC pathway</article-title><source>Science</source><year>1998</year><volume>281</volume><fpage>1509</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">9727977</pub-id></citation></ref><ref id="bib15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>K.U.</given-names></name><name><surname>Reynolds</surname><given-names>S.D.</given-names></name><name><surname>Watkins</surname><given-names>S.</given-names></name><name><surname>Fuchs</surname><given-names>E.</given-names></name><name><surname>Stripp</surname><given-names>B.R.</given-names></name></person-group><article-title>Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium</article-title><source>Am. J. Pathol.</source><year>2004</year><volume>164</volume><fpage>577</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">14742263</pub-id></citation></ref><ref id="bib16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horsley</surname><given-names>V.</given-names></name><name><surname>Aliprantis</surname><given-names>A.O.</given-names></name><name><surname>Polak</surname><given-names>L.</given-names></name><name><surname>Glimcher</surname><given-names>L.H.</given-names></name><name><surname>Fuchs</surname><given-names>E.</given-names></name></person-group><article-title>NFATc1 balances quiescence and proliferation of skin stem cells</article-title><source>Cell</source><year>2008</year><volume>132</volume><fpage>299</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">18243104</pub-id></citation></ref><ref id="bib17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horsley</surname><given-names>V.</given-names></name><name><surname>O'Carroll</surname><given-names>D.</given-names></name><name><surname>Tooze</surname><given-names>R.</given-names></name><name><surname>Ohinata</surname><given-names>Y.</given-names></name><name><surname>Saitou</surname><given-names>M.</given-names></name><name><surname>Obukhanych</surname><given-names>T.</given-names></name><name><surname>Nussenzweig</surname><given-names>M.</given-names></name><name><surname>Tarakhovsky</surname><given-names>A.</given-names></name><name><surname>Fuchs</surname><given-names>E.</given-names></name></person-group><article-title>Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland</article-title><source>Cell</source><year>2006</year><volume>126</volume><fpage>597</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">16901790</pub-id></citation></ref><ref id="bib18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>S.Y.</given-names></name><name><surname>Kudo</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Nakabayashi</surname><given-names>K.</given-names></name><name><surname>Bhalla</surname><given-names>A.</given-names></name><name><surname>van der Spek</surname><given-names>P.J.</given-names></name><name><surname>van Duin</surname><given-names>M.</given-names></name><name><surname>Hsueh</surname><given-names>A.J.</given-names></name></person-group><article-title>The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): Identification of LGR6 and LGR7 and the signaling mechanism for LGR7</article-title><source>Mol. Endocrinol.</source><year>2000</year><volume>14</volume><fpage>1257</fpage><lpage>1271</lpage><pub-id pub-id-type="pmid">10935549</pub-id></citation></ref><ref id="bib19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Nguyen</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>F.</given-names></name><name><surname>Morris</surname><given-names>R.J.</given-names></name><name><surname>Cotsarelis</surname><given-names>G.</given-names></name></person-group><article-title>Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis</article-title><source>Nat. Med.</source><year>2005</year><volume>11</volume><fpage>1351</fpage><lpage>1354</lpage><pub-id pub-id-type="pmid">16288281</pub-id></citation></ref><ref id="bib20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Andl</surname><given-names>T.</given-names></name><name><surname>Cui</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><name><surname>Millar</surname><given-names>S.E.</given-names></name><name><surname>Cotsarelis</surname><given-names>G.</given-names></name></person-group><article-title>Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>316</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">17507982</pub-id></citation></ref><ref id="bib21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaks</surname><given-names>V.</given-names></name><name><surname>Barker</surname><given-names>N.</given-names></name><name><surname>Kasper</surname><given-names>M.</given-names></name><name><surname>van Es</surname><given-names>J.H.</given-names></name><name><surname>Snippert</surname><given-names>H.J.</given-names></name><name><surname>Clevers</surname><given-names>H.</given-names></name><name><surname>Toftgard</surname><given-names>R.</given-names></name></person-group><article-title>Lgr5 marks cycling, yet long-lived, hair follicle stem cells</article-title><source>Nat. Genet.</source><year>2008</year><volume>40</volume><fpage>1291</fpage><lpage>1299</lpage><pub-id pub-id-type="pmid">18849992</pub-id></citation></ref><ref id="bib22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>K.B.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>11958</fpage><lpage>11963</lpage><pub-id pub-id-type="pmid">16877544</pub-id></citation></ref><ref id="bib23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>U.B.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Triel</surname><given-names>C.</given-names></name><name><surname>Woo</surname><given-names>S.H.</given-names></name><name><surname>Christensen</surname><given-names>R.</given-names></name><name><surname>Owens</surname><given-names>D.M.</given-names></name></person-group><article-title>A distinct population of clonogenic and multipotent murine follicular keratinocytes residing in the upper isthmus</article-title><source>J. Cell Sci.</source><year>2008</year><volume>121</volume><fpage>609</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">18252795</pub-id></citation></ref><ref id="bib24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>P.H.</given-names></name><name><surname>Simons</surname><given-names>B.D.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Sic transit gloria: Farewell to the epidermal transit amplifying cell?</article-title><source>Cell Stem Cell</source><year>2007</year><volume>1</volume><fpage>371</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">18371376</pub-id></citation></ref><ref id="bib25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>S.</given-names></name><name><surname>Niwa</surname><given-names>H.</given-names></name><name><surname>Tashiro</surname><given-names>F.</given-names></name><name><surname>Sano</surname><given-names>S.</given-names></name><name><surname>Kondoh</surname><given-names>G.</given-names></name><name><surname>Takeda</surname><given-names>J.</given-names></name><name><surname>Tabayashi</surname><given-names>K.</given-names></name><name><surname>Miyazaki</surname><given-names>J.</given-names></name></person-group><article-title>A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination</article-title><source>FEBS Lett.</source><year>2000</year><volume>470</volume><fpage>263</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">10745079</pub-id></citation></ref><ref id="bib26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laederich</surname><given-names>M.B.</given-names></name><name><surname>Funes-Duran</surname><given-names>M.</given-names></name><name><surname>Yen</surname><given-names>L.</given-names></name><name><surname>Ingalla</surname><given-names>E.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Carraway</surname><given-names>K.L.</given-names></name><name><surname>Sweeney</surname><given-names>C.</given-names></name></person-group><article-title>The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>47050</fpage><lpage>47056</lpage><pub-id pub-id-type="pmid">15345710</pub-id></citation></ref><ref id="bib27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>V.</given-names></name><name><surname>Lindon</surname><given-names>C.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Harfe</surname><given-names>B.D.</given-names></name><name><surname>Morgan</surname><given-names>B.A.</given-names></name></person-group><article-title>Epidermal stem cells arise from the hair follicle after wounding</article-title><source>FASEB J.</source><year>2007</year><volume>21</volume><fpage>1358</fpage><lpage>1366</lpage><pub-id pub-id-type="pmid">17255473</pub-id></citation></ref><ref id="bib28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Lyle</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Cotsarelis</surname><given-names>G.</given-names></name></person-group><article-title>Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge</article-title><source>J. Invest. Dermatol.</source><year>2003</year><volume>121</volume><fpage>963</fpage><lpage>968</lpage><pub-id pub-id-type="pmid">14708593</pub-id></citation></ref><ref id="bib29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lo Celso</surname><given-names>C.</given-names></name><name><surname>Prowse</surname><given-names>D.M.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>1787</fpage><lpage>1799</lpage><pub-id pub-id-type="pmid">15084463</pub-id></citation></ref><ref id="bib30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lo Celso</surname><given-names>C.</given-names></name><name><surname>Berta</surname><given-names>M.A.</given-names></name><name><surname>Braun</surname><given-names>K.M.</given-names></name><name><surname>Frye</surname><given-names>M.</given-names></name><name><surname>Lyle</surname><given-names>S.</given-names></name><name><surname>Zouboulis</surname><given-names>C.C.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Characterization of bipotential epidermal progenitors derived from human sebaceous gland: Contrasting roles of c-Myc and beta-catenin</article-title><source>Stem Cells</source><year>2008</year><volume>26</volume><fpage>1241</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">18308950</pub-id></citation></ref><ref id="bib31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lustig</surname><given-names>B.</given-names></name><name><surname>Jerchow</surname><given-names>B.</given-names></name><name><surname>Sachs</surname><given-names>M.</given-names></name><name><surname>Weiler</surname><given-names>S.</given-names></name><name><surname>Pietsch</surname><given-names>T.</given-names></name><name><surname>Karsten</surname><given-names>U.</given-names></name><name><surname>van de Wetering</surname><given-names>M.</given-names></name><name><surname>Clevers</surname><given-names>H.</given-names></name><name><surname>Schlag</surname><given-names>P.M.</given-names></name><name><surname>Birchmeier</surname><given-names>W.</given-names></name><name><surname>Behrens</surname><given-names>J.</given-names></name></person-group><article-title>Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors</article-title><source>Mol. Cell. Biol.</source><year>2002</year><volume>22</volume><fpage>1184</fpage><lpage>1193</lpage><pub-id pub-id-type="pmid">11809809</pub-id></citation></ref><ref id="bib32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyle</surname><given-names>S.</given-names></name><name><surname>Christofidou-Solomidou</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Elder</surname><given-names>D.E.</given-names></name><name><surname>Albelda</surname><given-names>S.</given-names></name><name><surname>Cotsarelis</surname><given-names>G.</given-names></name></person-group><article-title>The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells</article-title><source>J. Cell Sci.</source><year>1998</year><volume>111</volume><fpage>3179</fpage><lpage>3188</lpage><pub-id pub-id-type="pmid">9763512</pub-id></citation></ref><ref id="bib33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Majo</surname><given-names>F.</given-names></name><name><surname>Rochat</surname><given-names>A.</given-names></name><name><surname>Nicolas</surname><given-names>M.</given-names></name><name><surname>Jaoude</surname><given-names>G.A.</given-names></name><name><surname>Barrandon</surname><given-names>Y.</given-names></name></person-group><article-title>Oligopotent stem cells are distributed throughout the mammalian ocular surface</article-title><source>Nature</source><year>2008</year><volume>456</volume><fpage>250</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">18830243</pub-id></citation></ref><ref id="bib34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>S.J.</given-names></name><name><surname>Spradling</surname><given-names>A.C.</given-names></name></person-group><article-title>Stem cells and niches: Mechanisms that promote stem cell maintenance throughout life</article-title><source>Cell</source><year>2008</year><volume>132</volume><fpage>598</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">18295578</pub-id></citation></ref><ref id="bib35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nijhof</surname><given-names>J.G.</given-names></name><name><surname>Braun</surname><given-names>K.M.</given-names></name><name><surname>Giangreco</surname><given-names>A.</given-names></name><name><surname>van Pelt</surname><given-names>C.</given-names></name><name><surname>Kawamoto</surname><given-names>H.</given-names></name><name><surname>Boyd</surname><given-names>R.L.</given-names></name><name><surname>Willemze</surname><given-names>R.</given-names></name><name><surname>Mullenders</surname><given-names>L.H.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name><name><surname>de Gruijl</surname><given-names>F.R.</given-names></name><name><surname>van Ewijk</surname><given-names>W.</given-names></name></person-group><article-title>The cell-surface marker MTS24 identifies a novel population of follicular keratinocytes with characteristics of progenitor cells</article-title><source>Development</source><year>2006</year><volume>133</volume><fpage>3027</fpage><lpage>3037</lpage><pub-id pub-id-type="pmid">16818453</pub-id></citation></ref><ref id="bib36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>J.A.</given-names></name><name><surname>Polak</surname><given-names>L.</given-names></name><name><surname>Pasolli</surname><given-names>H.A.</given-names></name><name><surname>Fuchs</surname><given-names>E.</given-names></name></person-group><article-title>Hair follicle stem cells are specified and function in early skin morphogenesis</article-title><source>Cell Stem Cell</source><year>2008</year><volume>3</volume><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">18593557</pub-id></citation></ref><ref id="bib37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>D.M.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Contribution of stem cells and differentiated cells to epidermal tumours</article-title><source>Nat. Rev. Cancer</source><year>2003</year><volume>3</volume><fpage>444</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">12778134</pub-id></citation></ref><ref id="bib38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silva-Vargas</surname><given-names>V.</given-names></name><name><surname>Lo Celso</surname><given-names>C.</given-names></name><name><surname>Giangreco</surname><given-names>A.</given-names></name><name><surname>Ofstad</surname><given-names>T.</given-names></name><name><surname>Prowse</surname><given-names>D.M.</given-names></name><name><surname>Braun</surname><given-names>K.M.</given-names></name><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells</article-title><source>Dev. Cell</source><year>2005</year><volume>9</volume><fpage>121</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">15992546</pub-id></citation></ref><ref id="bib39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soucek</surname><given-names>L.</given-names></name><name><surname>Whitfield</surname><given-names>J.</given-names></name><name><surname>Martins</surname><given-names>C.P.</given-names></name><name><surname>Finch</surname><given-names>A.J.</given-names></name><name><surname>Murphy</surname><given-names>D.J.</given-names></name><name><surname>Sodir</surname><given-names>N.M.</given-names></name><name><surname>Karnezis</surname><given-names>A.N.</given-names></name><name><surname>Swigart</surname><given-names>L.B.</given-names></name><name><surname>Nasi</surname><given-names>S.</given-names></name><name><surname>Evan</surname><given-names>G.I.</given-names></name></person-group><article-title>Modelling Myc inhibition as a cancer therapy</article-title><source>Nature</source><year>2008</year><volume>455</volume><fpage>679</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">18716624</pub-id></citation></ref><ref id="bib40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Miura</surname><given-names>H.</given-names></name><name><surname>Tanemura</surname><given-names>A.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Kondoh</surname><given-names>G.</given-names></name><name><surname>Sano</surname><given-names>S.</given-names></name><name><surname>Ozawa</surname><given-names>K.</given-names></name><name><surname>Inui</surname><given-names>S.</given-names></name><name><surname>Nakata</surname><given-names>A.</given-names></name><name><surname>Takagi</surname><given-names>T.</given-names></name></person-group><article-title>Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia</article-title><source>FEBS Lett.</source><year>2002</year><volume>521</volume><fpage>67</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12067728</pub-id></citation></ref><ref id="bib41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tani</surname><given-names>H.</given-names></name><name><surname>Morris</surname><given-names>R.J.</given-names></name><name><surname>Kaur</surname><given-names>P.</given-names></name></person-group><article-title>Enrichment for murine keratinocyte stem cells based on cell surface phenotype</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2000</year><volume>97</volume><fpage>10960</fpage><lpage>10965</lpage><pub-id pub-id-type="pmid">11005869</pub-id></citation></ref><ref id="bib42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trempus</surname><given-names>C.S.</given-names></name><name><surname>Morris</surname><given-names>R.J.</given-names></name><name><surname>Bortner</surname><given-names>C.D.</given-names></name><name><surname>Cotsarelis</surname><given-names>G.</given-names></name><name><surname>Faircloth</surname><given-names>R.S.</given-names></name><name><surname>Reece</surname><given-names>J.M.</given-names></name><name><surname>Tennant</surname><given-names>R.W.</given-names></name></person-group><article-title>Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34</article-title><source>J. Invest. Dermatol.</source><year>2003</year><volume>120</volume><fpage>501</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">12648211</pub-id></citation></ref><ref id="bib43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vasioukhin</surname><given-names>V.</given-names></name><name><surname>Degenstein</surname><given-names>L.</given-names></name><name><surname>Wise</surname><given-names>B.</given-names></name><name><surname>Fuchs</surname><given-names>E.</given-names></name></person-group><article-title>The magical touch: Genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>8551</fpage><lpage>8556</lpage><pub-id pub-id-type="pmid">10411913</pub-id></citation></ref><ref id="bib44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waikel</surname><given-names>R.L.</given-names></name><name><surname>Kawachi</surname><given-names>Y.</given-names></name><name><surname>Waikel</surname><given-names>P.A.</given-names></name><name><surname>Wang</surname><given-names>X.J.</given-names></name><name><surname>Roop</surname><given-names>D.R.</given-names></name></person-group><article-title>Deregulated expression of c-Myc depletes epidermal stem cells</article-title><source>Nat. Genet.</source><year>2001</year><volume>28</volume><fpage>165</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">11381265</pub-id></citation></ref><ref id="bib45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walzer</surname><given-names>C.</given-names></name><name><surname>Benathan</surname><given-names>M.</given-names></name><name><surname>Frenk</surname><given-names>E.</given-names></name></person-group><article-title>Thermolysin treatment: A new method for dermo-epidermal separation</article-title><source>J. Invest. Dermatol.</source><year>1989</year><volume>92</volume><fpage>78</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">2642514</pub-id></citation></ref><ref id="bib46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watt</surname><given-names>F.M.</given-names></name></person-group><article-title>Role of integrins in regulating epidermal adhesion, growth and differentiation</article-title><source>EMBO J.</source><year>2002</year><volume>21</volume><fpage>3919</fpage><lpage>3926</lpage><pub-id pub-id-type="pmid">12145193</pub-id></citation></ref><ref id="bib47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watt</surname><given-names>F.M.</given-names></name><name><surname>Hogan</surname><given-names>B.L.</given-names></name></person-group><article-title>Out of Eden: Stem cells and their niches</article-title><source>Science</source><year>2000</year><volume>287</volume><fpage>1427</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">10688781</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Lrig1 Expression Defines a Distinct Population of Epidermal Cells in the Junctional Zone</p><p>(A&#x02013;H) Immunofluorescence labeling of sections of embryonic (A) and adult back (C) and tail (D) skin and whole mounts of embryonic (B) and adult (E&#x02013;H) tail epidermis. Adult skin was in telogen (C&#x02013;F and H) or early anagen (G). Skin was from wild-type (A, B, upper panel of C, D, E, G, and H) or <italic>Lrig1</italic>-null mice (lower panel of C, F).</p><p>Insert in (G) shows the bulb at a higher magnification. Color coding indicates antibody labeling. Dashed lines represent the boundary between dermis and epidermis (A and C) or demarcate hair follicles (B and G).</p><p>epi, epidermis; de, dermis; IFE, interfollicular epidermis; SG, sebaceous gland; JZ, junctional zone; BU, bulge; BB, bulb; HFSC, developing hair follicle stem cell compartment; PL, hair follicle placode; HG, hair germ. (A) is shown at a higher magnification in <xref rid="app2" ref-type="sec">Figures S1</xref>F&#x02013;S1H. Scale bars, 25 &#x003bc;m (A and D) and 100 &#x003bc;m (B and E&#x02013;H).</p><p>(I) Diagram illustrating the different regions of adult epidermis. Red, junctional zone; green, bulge.</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Characterization of Lrig1-Expressing Cells in Adult Epidermis</p><p>(A&#x02013;D) Immunofluorescence labeling of tail epidermal whole mounts from wild-type mice. Skin was in anagen (A) or telogen (B&#x02013;D). Color coding indicates antibody labeling. Scale bars, 100 &#x003bc;m.</p><p>(E) Flow cytometry of telogen epidermis from wild-type (WT) and <italic>Lrig1</italic>-null (KO) epidermis disaggregated with thermolysin and labeled with antibodies to &#x003b1;6 integrin, Lrig1, CD34, and Sca1. Colored gates in top-right panel correspond to populations in lower-right panel and in (F) and (G).</p><p>(F) Colony-forming efficiency of wild-type primary keratinocytes isolated as in (E).</p><p>(G) Q-PCR of RNA from 10<sup>5</sup> wild-type epidermal cells isolated as in (E).</p><p>(F and G) Data are means &#x000b1; SEM (n &#x0003d; 4).</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Epidermal Reconstitution by Lrig1-Expressing Cells</p><p>(A&#x02013;C) Keratinocytes isolated from the back skin of wild-type adult telogen (7-week-old) mice were sorted into &#x003b1;6 integrin-high (I) and -low (II) populations (A). Populations I (B) and II (C) were gated into three further populations on the basis of Sca1 and CD34 expression, yielding a total of six discrete populations of keratinocytes (1&#x02013;3 in [B]; 4&#x02013;6 in [C]).</p><p>(D) RNA from each of the six populations or total live cells (low forward/side scatter; all) were analyzed using Q-PCR for the genes indicated (mean &#x000b1; SEM, n &#x0003d; 5).</p><p>(E&#x02013;P) Epidermal cells from telogen back skin of GFP-expressing mice were fractionated based on Sca1, &#x003b1;6 integrin, and CD34 expression as in (A)&#x02013;(C) or Lrig1 (as in <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>E) for epidermal reconstitution experiments by mixing GFP-positive and GFP-negative epidermal cells. Four cell populations were compared: &#x003b1;6 high (ItgA6H), CD34 positive, Sca1 negative (population 1; enriched for bulge cells; [E], [I], and [M]); &#x003b1;6 high, CD34 negative, Sca1 negative (population 2; enriched for Lrig1-positive cells; [F], [J], and [N]); &#x003b1;6 high, CD34 negative, SCA1 positive (population 3; [G], [K], and [O]); or Lrig1 positive ([H], [L], [P]). (E&#x02013;H) Dermal view of&#x000a0;grafts; (I-P) Sections of grafts labeled with GFP antibody (brown) and hematoxylin counterstain (blue). Interfollicular epidermis (IFE), hair follicles (HF), and sebaceous glands (SG) are indicated. Scale bars, 100 &#x003bc;m (I&#x02013;L) and 25 &#x003bc;m (M&#x02013;P).</p></caption><graphic xlink:href="gr3"/></fig><fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Effects of <italic>Lrig1</italic> Loss In Vivo</p><p>(A and B) Hematoxylin and eosin-stained sections of adult tail skin.</p><p>(C and D) Macroscopic view of adult tails.</p><p>(E, I, G, H, K, L, N, and O) Tail whole mounts of P1 (G and K) and adult telogen (E, I, N, and O) and anagen (H and L) epidermis. WT, wild-type; KO, <italic>Lrig1</italic> null. Color coding indicates antibody labeling.</p><p>(F and J) Flow cytometry of (F) WT and (J) KO Sca1-low cells with antibodies to CD34 and &#x003b1;6 integrin. The percentage of cells in each quadrant is indicated.</p><p>(M) Quantitation of Ki67-positive cells in KO IFE expressed relative to WT controls. Data shows mean &#x000b1; SEM; average of three fields per whole mount and five mice per sample.</p><p>(N&#x02013;P) BrdU label-retaining cells were examined following a 70 day chase period.</p><p>(P) Cells were subjected to flow cytometry with antibodies to Sca1, CD34, and &#x003b1;6 integrin. The percentage of cells in each group that were BrdU labeled is shown. Error bars represent SD (WT n &#x0003d; 8; KO n &#x0003d; 6). WT, wild-type; KO, <italic>Lrig1</italic> null.</p><p>Scale bars, 100 &#x003bc;m (A, B, G, H, K, M, and O) and 200 &#x003bc;m (E and I).</p></caption><graphic xlink:href="gr4"/></fig><fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Regulation of Lrig1 Expression by Myc</p><p>(A) (Top) Immunoblot of protein lysates from tail skin of adult littermates lacking (KO) or heterozygous (Het) for <italic>Lrig1</italic>. Each lane contains protein from a separate mouse. Blot was probed for Myc or, as a loading control, &#x003b2;-tubulin (Tub). (Bottom) Q-PCR for <italic>cMyc</italic> from adult littermates lacking (KO) or heterozygous (Het) for <italic>Lrig1</italic>. Expression levels are relative to <italic>Gapdh</italic>, and error bars represent SD (n &#x0003d; 3).</p><p>(B) Q-PCR for <italic>Lrig1</italic> mRNA in back skin of WT and <italic>K14MycER</italic>-transgenic mice treated with 4OHT for 8 days. Expression levels are relative to <italic>Gapdh</italic>, and error bars represent SD (n &#x0003d; 3).</p><p>(C) Luciferase assay using 1.6 kb of the <italic>Lrig1</italic> promoter in murine keratinocytes from WT or <italic>K14MycER</italic> mice, represented as induction in <italic>K14MycER</italic> cells relative to WT cells. Cells were treated with the 4OHT concentrations indicated (nM). Error bars represent SD (n &#x0003d; 4).</p><p>(D&#x02013;G) Back skin sections (D and E) and tail epidermal whole mounts (F and G) of wild-type (WT) and <italic>K14MycER</italic> mice treated with 4OHT for the number of days shown. Color coding indicates antibody labeling. Scale bars, 100 &#x003bc;m.</p><p>(H) Location of two E boxes in the <italic>Lrig1</italic> promoter.</p><p>(I) Quantitative ChIP from keratinocytes isolated from back skin of WT or <italic>K14MycER</italic>-transgenic mice treated with 4OHT for 4 days.</p><p>(J) Knockdown of <italic>cMyc</italic> in primary cultures of WT keratinocytes causes a decrease in <italic>Lrig1</italic> transcript levels. Error bars represent SD (n &#x0003d; 4).</p></caption><graphic xlink:href="gr5"/></fig><fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>Lineage Analysis of Junctional Zone Cells</p><p>(A) Schematic summary of the two mouse lines that were crossed for lineage tracing. Leakiness of Cre expression in the absence of 4OHT was exploited for clonal analysis.</p><p>(B and C) Sections of back skin stained for GFP, showing two examples of junctional zone clones. (B&#x02032;) Insert in (B) shown at higher magnification.</p><p>(D) Schematic diagram showing contribution of junctional zone clones (green) to IFE and SG in control (left) and ATRA-treated skin.</p><p>(E) Cumulative frequency plots of the size distribution of GFP-positive clones originating in the IFE, junctional zone, infundibulum, SG, and HF (below the level of the SG). Clone size (volume) was determined from 3D reconstructions of confocal images. Diagrams represent ranking based on cumulative percentage of clones as a function of clone size (exponential scale) in control (blue) and ATRA-treated (red) skin.</p><p>(F and G) Three-dimensional projections of whole-mount reconstructions stained for GFP and LRIG1. Color coding indicates antibody labeling. GFP expression is shown by isosurface labeling. (F) Control. (G) Treated with ATRA.</p><p>(H) Clone size distribution in control (ctrl) and ATRA-treated skin. Data from (E) are replotted as box and whisker plot of GFP clone sizes (volume) in the different epidermal regions in control and ATRA-treated tail epidermis. Minimum and maximum clone sizes are marked by whiskers; upper and lower box boundaries indicate clones in the 25th to 75th percentile, and cross (&#x0002b;) indicates median clone size. Asterisk indicates statistically significant change in median clone size following ATRA treatment (p &#x0003c; 0.05, two-tailed unpaired Mann-Whitney test). Scale bars, 100 &#x003bc;m (B, C, F, and G) and 25 &#x003bc;m (B&#x02032;).</p></caption><graphic xlink:href="gr6"/></fig><fig id="fig7"><label>Figure&#x000a0;7</label><caption><p>Effect of <italic>Lrig1</italic> Loss on Stem Cell Renewal and Responsiveness to &#x003b2;-Catenin Activation</p><p>(A) Clonal growth assays of primary keratinocytes sorted based on CD34, Sca1, and &#x003b1;6 integrin (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A&#x02013;C) from the skin of wild-type (WT) and <italic>Lrig1</italic>-null (KO) adult littermates. Error bars represent SD (n &#x0003d; 3). Six-hundred Sca1-negative cells and 2500 Sca1-positive and unfractionated cells were seeded; representative dishes are shown.</p><p>(B and C) Tail epidermal whole mounts of WT and <italic>K14&#x00394;N&#x003b2;-cateninER</italic> mice treated with 4OHT for 3 weeks. Arrow and insert indicate Lrig1-positive ectopic follicles in interfollicular epidermis.</p><p>(D and E) Flow cytometric analysis for Lrig1 and &#x003b1;6 integrin of cells from WT and <italic>K14&#x00394;N&#x003b2;-cateninER</italic> mice treated with 4OHT for 3 weeks. The proportion of cells in each fraction is indicated.</p><p>(F) Q-PCR of <italic>Lrig1</italic> and <italic>cMyc</italic> mRNA in back skin of WT and <italic>K14&#x00394;N&#x003b2;-cateninER</italic>-transgenic mice treated with 4OHT for 2 weeks. Expression levels are relative to <italic>Gapdh</italic>, and error bars represent SD (n &#x0003d; 3).</p><p>(G) Q-PCR of levels of <italic>Lrig1</italic>, Axin2, and Jagged1 in primary murine epidermal keratinocytes treated with Wnt3A. Data are expressed relative to unstimulated cells. Error bars represent SD (n &#x0003d; 3).</p><p>(H) ChIP analysis of endogenous cMyc on the <italic>Lrig1</italic> promoter in WT and <italic>K14&#x00394;N&#x003b2;-cateninER</italic> mice treated with 4OHT for 10 days. Data represent two separate samples and show level of isolated genomic DNA relative to amount of input DNA.</p><p>(I&#x02013;M) Hematoxylin and eosin stained sections (I and J) and whole mounts (L and M) of adult tail epidermis from <italic>K14&#x00394;N&#x003b2;-cateninER</italic> &#x000d7; <italic>Lrig1</italic> heterozygous (het) or knockout (KO) mice treated with 4OHT for 3 weeks. The number of ectopic HFs formed from the interfollicular epidermis was scored by morphology (K) and by the appearance of clusters of CDP-expressing cells (N) (two independent experiments; KO, n &#x0003d; 8; WT, n &#x0003d; 7). Arrows in (J) indicate expanded infundibulum with associated ectopic follicles.</p><p>In (B), (C), (L), and (M), color coding indicates antibody labeling. Scale bars, 100 &#x003bc;m (B and C) and 200 &#x003bc;m (I, J, L, and M).</p></caption><graphic xlink:href="gr7"/></fig></floats-wrap></article> 